Dialogue Health Technologies (TSX:CARE) - Aandelenkoers, Nieuws & Analyse

CARE Overzicht aandelen

Dialogue Health Technologies Inc. operates a digital healthcare and wellness platform in Canada, the United Kingdom, Germany, and Internationally. Meer informatie

CARE fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	4/6
Prestaties in het verleden	0/6
Financiële gezondheid	4/6
Dividenden	0/6

Beloningen

Verhandeld tegen 84.7% onder onze schatting van de reële waarde

De winst zal naar verwachting met 119.22% per jaar groeien

De winst is de afgelopen 5 jaar met 7.2% per jaar gegroeid

Risicoanalyse

Geen risico's gedetecteerd voor CARE uit onze risicocontroles.

Dialogue Health Technologies Inc. Concurrenten

Viemed Healthcare

TSX:VMD

CA$311.8m

Healwell AI

TSX:AIDX

CA$259.5m

Quipt Home Medical

TSX:QIPT

CA$144.4m

WELL Health Technologies

TSX:WELL

CA$1.3b

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Dialogue Health Technologies
Historische aandelenkoersen
Huidige aandelenkoers	CA$5.14
52 Week Hoogtepunt	CA$5.16
52 Week Laag	CA$2.05
Bèta	2.78
11 maand verandering	0.69%
3 maanden verandering	66.88%
1 Jaar Verandering	106.43%
33 jaar verandering	n/a
5 jaar verandering	n/a
Verandering sinds IPO	-63.96%

Recent nieuws en updates

Recent updates

Dialogue Health Technologies Inc.'s (TSE:CARE) Intrinsic Value Is Potentially 90% Above Its Share Price

Mar 14

Dialogue Health Technologies Inc. (TSE:CARE) Just Reported Earnings, And Analysts Cut Their Target Price

Nov 17

An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 37% Undervalued

Jun 28

An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 48% Undervalued

Feb 11

Calculating The Fair Value Of Dialogue Health Technologies Inc. (TSE:CARE)

Nov 07

Rendement voor aandeelhouders

	CARE	CA Healthcare	CA Markt
7D	0.2%	0.2%	2.2%
1Y	106.4%	39.2%	23.4%

Rendement versus industrie: CARE overtrof de Canadian Healthcare industrie, die het afgelopen jaar een rendement 39.2 % opleverde.

Rendement versus markt: CARE overtrof de Canadian markt, die het afgelopen jaar een rendement opleverde van 23.4 %.

Prijsvolatiliteit

Is CARE's price volatile compared to industry and market?
CARE volatility
CARE Average Weekly Movement	12.0%
Healthcare Industry Average Movement	4.2%
Market Average Movement	8.3%
10% most volatile stocks in CA Market	17.7%
10% least volatile stocks in CA Market	2.9%

Stabiele aandelenkoers: De aandelenkoers van CARE is de afgelopen 3 maanden volatiel geweest.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 12% ) van CARE is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
2016	240	Cherif Habib	dialogue.co

Dialogue Health Technologies Inc. Samenvatting

Hoe verhouden de winst en inkomsten van Dialogue Health Technologies zich tot de beurswaarde?
CARE fundamentele statistieken
Marktkapitalisatie	CA$345.99m
Inkomsten(TTM)	-CA$19.50m
Inkomsten(TTM)	CA$95.88m

3.6x

P/S-verhouding

-17.8x

Koers/Winstverhouding

Is CARE overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
CARE resultatenrekening (TTM)
Inkomsten	CA$95.88m
Kosten van inkomsten	CA$41.84m
Brutowinst	CA$54.03m
Overige uitgaven	CA$73.54m
Inkomsten	-CA$19.50m

Laatst gerapporteerde inkomsten

Jun 30, 2023

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.29
Brutomarge	56.36%
Nettowinstmarge	-20.34%
Schuld/Eigen Vermogen Verhouding	1.0%

Hoe presteerde CARE op de lange termijn?

Bekijk historische prestaties en vergelijking

CARE Overzicht aandelen

Beloningen

Risicoanalyse

Dialogue Health Technologies Inc. Concurrenten

TSX:VMD

CA$311.8m

TSX:AIDX

CA$259.5m

TSX:QIPT

CA$144.4m

TSX:WELL

CA$1.3b

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Dialogue Health Technologies Inc. to Appoint Swati Matta as Head of Women's Health

Sun Life Assurance Company of Canada completed the acquisition of an additional 74.8% stake in Dialogue Health Technologies Inc. (TSX:CARE) from a group of shareholders.

Forecast breakeven date moved forward to 2024

Consensus EPS estimates fall by 22%

First quarter 2023 earnings released: CA$0.04 loss per share (vs CA$0.10 loss in 1Q 2022)

Forecast breakeven date moved forward to 2024

Recent updates

Dialogue Health Technologies Inc. to Appoint Swati Matta as Head of Women's Health

Sun Life Assurance Company of Canada completed the acquisition of an additional 74.8% stake in Dialogue Health Technologies Inc. (TSX:CARE) from a group of shareholders.

Forecast breakeven date moved forward to 2024

Consensus EPS estimates fall by 22%

First quarter 2023 earnings released: CA$0.04 loss per share (vs CA$0.10 loss in 1Q 2022)

Forecast breakeven date moved forward to 2024

Dialogue Health Technologies Inc. to Report Q2, 2023 Results on Aug 14, 2023

Sun Life Financial Inc. (TSX:SLF) entered into an agreement to acquire a 74.8% stake in Dialogue Health Technologies Inc. (TSX:CARE) from a group of shareholders for approximately CAD 270 million.

Sun Life Financial Inc. (TSX:SLF) entered into an agreement to acquire a 74.8% stake in Dialogue Health Technologies Inc. (TSX:CARE) from a group of shareholders for approximately CAD 270 million.

Dialogue Health Technologies Inc. Provides Revenue Guidance for the Second Quarter of 2023

Forecast to breakeven in 2025

First quarter 2023 earnings: EPS exceeds analyst expectations

Full year 2022 earnings: EPS in line with expectations, revenues disappoint

Dialogue Health Technologies Inc.'s (TSE:CARE) Intrinsic Value Is Potentially 90% Above Its Share Price

Dialogue Health Technologies Inc. Provides Earnings Guidance for the Three-Month Period Ending December 31, 2022

An unknown buyer entered into a definitive agreement to acquire Occupational Health Safety ("OHS") service in Germany from Dialogue Health Technologies Inc. (TSX:CARE).

Co-Founder exercised options to buy CA$250k worth of stock.

No longer forecast to breakeven

Dialogue Health Technologies Inc. (TSE:CARE) Just Reported Earnings, And Analysts Cut Their Target Price

Price target decreased to CA$5.03

Dialogue Health Technologies Inc. Provides Earnings Guidance for the Fourth Quarter of 2022

High number of new directors

Dialogue Health Technologies Inc. to Report Q3, 2022 Results on Nov 14, 2022

Sterling Capital Brokers partners with Dialogue Health Technologies Inc. to Launch First-Ever Integrated Virtual Health Program

Dialogue Health Technologies Inc. Provides Earnings Outlook for the Third Quarter of 2022

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased to CA$7.17

Dialogue Health Technologies Inc. to Report Q2, 2022 Results on Aug 10, 2022

An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 37% Undervalued

Now 25% undervalued after recent price drop

Independent Director exercised options to buy CA$62k worth of stock.

Dialogue Health Technologies Inc. Announces Executive Changes

Forecast to breakeven in 2024

Price target decreased to CA$9.17

First quarter 2022 earnings: EPS misses analyst expectations

High number of new directors

Dialogue Health Technologies Inc. Launches Mental Health+, Responding to Evolving Mental Health Challenges in Organizations

Dialogue Health Technologies Inc. (TSX:CARE) entered into an agreement to acquire Tictrac Limited for £35 million.

Consensus forecasts updated

Dialogue Health Technologies Inc. (TSX:CARE) entered into an agreement to acquire Tictrac Limited for £35 million.

Consensus EPS estimates fall by 10%

Dialogue Health Technologies Inc., Annual General Meeting, May 16, 2022

Dialogue Health Technologies Inc. to Report Q4, 2021 Results on Mar 23, 2022

An Intrinsic Calculation For Dialogue Health Technologies Inc. (TSE:CARE) Suggests It's 48% Undervalued

Sun Life Assurance Company of Canada acquired an additional 9.18% stake in Dialogue Health Technologies Inc. (TSX:CARE) for CAD 48.3 million.

Third quarter 2021 earnings released: CA$0.10 loss per share

Calculating The Fair Value Of Dialogue Health Technologies Inc. (TSE:CARE)

Co-Founder recently bought CA$70k worth of stock

Dialogue Health Technologies Inc. (TSX:CARE) acquired eHub Health Pty Limited.

Co-Founder & CEO recently bought CA$1.8m worth of stock

Rendement voor aandeelhouders

Prijsvolatiliteit

Over het bedrijf

Dialogue Health Technologies Inc. Samenvatting

3.6x

-17.8x

Inkomsten en omzet